NASDAQ:PROF (Profound Medical Corp.)

Profound is a commercial-stage medical device company and an innovator in interventional MRI procedures, enabling precise, incision-free therapies that improve clinical confidence, procedural control, and patient outcomes. By leveraging real-time MRI guidance, Profound's technologies are designed to replace uncertainty with clarity across treatment planning, delivery, and confirmation. The company's flagship platform, TULSA-PRO ®, enables MRI-guided, incision-free prostate therapy designed for precision and flexibility. The TULSA Procedure¿ allows physicians to see, treat, and confirm therapy in real time, supporting personalized treatment strategies across the continuum of prostate care-from whole-gland to subtotal, hemi, multifocal, and focal treatment.